Pediatric aggressive fibromatosis: A retrospective analysis of 13 patients and review of the literature

Cancer

Volumn 104, Issue 5, 2005, Pages 1090-1099

  Buitendijk, Saskia ^a   Van De Ven, Cees P ^a   Dumans, Ton G ^a   Den Hollander, Jan C ^a   Nowak, Peter J ^a   Tissing, Wim J ^a   Pieters, Rob ^a   Van Den Heuvel Eibrink, Marry M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Aggressive fibromatosis; Childhood cancer; Desmoid tumor; General recommendations; Review; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER REGRESSION; CARDIOTOXICITY; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; FIBROMATOSIS; FOLLOW UP; HUMAN; INFANT; MALE; PREOPERATIVE TREATMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RARE DISEASE; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SCHOOL CHILD; SOFT TISSUE TUMOR; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROMATOSIS, AGGRESSIVE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS;

EID: 23844504616     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21275     Document Type: Review

References (37)

1. Fletcher CDM, Krishnan Unni K, Merlens F. World Health Organization: tumours of soft tissue and bone. Lyon, France: IARC Press, 2002.
2. Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue tumors, 4th edition. St Louis: Mosby, 2001.
3. Reitamo JJ, Scheinin TM, Hayry P. The desmoid syndrome: mew aspects in the cause, pathogenesis and treatment of the desmoid tumor. Am J Surg. 1986;151:230-237.
4. Atahan IL, Akyol F, Zorlu F, Gürkaynak M. Radiotherapy in the management of aggressive fibromatosis. Br J Radiol. 1989;62:854-856.
5. Ayala AG, Ro JY, Goepfert H, Cangir A, Khorsand J, Flake G. Desmoid fibromatosis: a clinicopathologic study of 25 children. Semin Diagn Pathol. 1986;3:138-150.
6. Faulkner LB, Hajdu SI, Kher U, et al. Pediatrie desmoid tumor: retrospective analysis of 63 cases. J Clin Oncol. 1995; 13:2813-2818.
7. Godzinski J, Sulka W, Rapala M, et al. Aggressive fibromatosis: a challenge for paediatric oncological surgery. Pediatr Blood Cancer. 2003;41:278.
8. Rao BN, Horowitz ME, Parham DM, et al. Challenges in the treatment of childhood fibromatosis. Arch Surg. 1987;122: 1296-1298.
9. Reich S, Overberg-Schmidt US, Bührer C, Henze G. Correspondence re: low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors [letter]. J Clin Oncol. 1999;17:1086.
10. Scougall P, Staheli LT, Chew DE, Taylor TKF, Almquist EE. Desmoid tumors in childhood. Orthop Rev. 1987;16:481-488.
11. Skapek SX, Hawk BJ, Hoffer FA, et al. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. J Clin Oncol. 1998;16:3021-3027.
12. Spiegel DA, Dormans JP, Meyer JS, et al. Aggressive fibromatosis from infancy to adolescence. J Pediatr Orthop. 1999; 19:776-784.
13. Wever de I, Cin dal P, Fletcher CDM, et al. Cytogenetic, clinical, and morphologic correlations in 78 cases of fibromatosis: a report from the CHAMP Study Group. Mod Pathol. 2000;13:1080-1085.
14. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene. 1999;18: 6615-6620.
15. Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ. Increased β-catenin protein and somatic APC mutations in sporadic aggressive fibromatosis (desmoid tumors). Am J Pathol. 1997;151:329-334.
16. Li C, Bapat B, Alman BA. Adenomatous polyposis coli gene mutation alters proliferation through its β-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol. 1998;153:709-714.
17. Lackner H, Urban C, Kerbl R, Schwinger W, Beham. A noncytotoxic drug therapy in children with unresectable desmoid tumors. Cancer. 1997;80:334-340.
18. Janinis J, Patriki M, Vini G, Aravantinos G, Whelan JS. The pharmalogical treatment of aggressive fibromatosis: a systematic review. Ann Oncol. 2003;14:181-190.
19. Bertario L, Russo A, Sala P, et al. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol. 2003;21:1698-1707.
20. Piza-Katzer H, Rhomberg M. Extra-abdominelle fibromatose-extra- abdominelles desmoïd. Chirurg. 2000;71:904-911.
21. Dormans JP, Spiegel D, Meyer J, et al. Fibromatoses in childhood: the desmoid/fibromatosis complex. Pediatr Blood Cancer. 2001;37:126-131.
22. Ballo MT, Zagars GK, Pollack A, Pisters PWT, Pollock RA. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiotherapy. J Clin Oncol. 1999;17:158-167.
23. Goy BW, Lee SP, Eilber F, et al. The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys. 1997;39:659-665.
24. Gronchi A, Casali PG, Mariani L, et al. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. J Clin Oncol. 2003;21:1390-1397.
25. Spear MA, Jennings LC, Mankin HJ, et al. Individualizing management of aggressive fibromatosis. Int J Radiat Oncol Phys. 1998;40:637-645.
26. Merchant TE, Nguyen D, Walter AW, Pappo AS, Kun LE, Rao BA. Long-term results with radiation therapy for pediatric desmoid tumors. Int J Radiat Oncol Biol Phys. 2000;47:1267-1271.
27. Raney B, Evans A, Granowetter L, Schnaufer L, Uri A, Littman P. Nonsurgical management of children with recurrent or unresectable fibromatosis. Pediatrics. 1987;79:394-398.
28. Lucas DR, Shroyer KR, McCarthy PJ, Markham NE, Fujita M, Takayuki E. Desmoid tumor is a clonal cellular proliferation: PCR amplification of HUMARA for analysis of patterns of X-chromosome inactivation. Am J Surg Pathol. 1997;21:306-311.
29. Li M, Cordon-Cardo C, Gerald WL, Rosai J. Desmoid fibromatosis is a clonal process. Hum Pathol. 1996;27:939-943.
30. Denys H, Jadidizadeh A, Amini Nik S, et al. Identification of IGFBP-6 as a significantly downregulated gene by b-catenin in desmoid tumors. Oncogene. 2004;23:654-664.
31. Micke O, Seegenschmiedt MH. Radiation therapy for aggressive fibromatosis (desmoid tumors)-results of a national patterns of care study [abstract]. Int J Radiat Oncol Biol Phys. 2003;57:5252.
32. Nuyttens JJ, Rust PF, Thomas CR, Turrisi AT. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer. 2000;88:1517-1523.
33. Park HC, Pyo HR, Shin KH, Suh CO. Radiation treatment for aggressive fibromatosis: findings from observed patterns of local failure. Oncology. 2003;64:346-352.
34. Leithner A, Schnack B, Katterschafka T, et al. Treatment of extra-abdominal desmoid tumors with interferon-alpha with or without tretinoin. J Surg Oncol 2000;73:21-25.
35. Mace J, Biermann JS, Sondak V, et al. Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer. 2002;95:2373-2379.
36. Lackner H, Urban C, Benesch M, et al. Multimodal treatment of children with unresectable or recurrent desmoid tumors: an 11-year longitudinal observational study. J Pediatr Hematol Oncol. 2004;26:518-522.
37. Hansmann A, Vogel CAT, Unger A, Moeslein G. High-dose tamoxifen and sundilac as first-line treatment for desmoid tumors. Cancer. 2004;100:612-620.